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Glucose metabolism has a significant impact on inner 
ear physiology, and small changes may result in hearing 
and balance disorders. Aim: To investigate vestibulocochlear 
symptoms in patients with type I diabetes mellitus. Study 
design: a cross-sectional study of a contemporary group. 
Material and Method: 30 patients referred from Clinical 
Hospital-UFPR to the Laboratory of Otoneurology-UTP 
between Mar/2004 to Feb/2005 were evaluated. The 
following procedures were carried out: a medical history, 
otological inspections, audiometry, acoustic impedance 
tests, and vestibular function tests. Results: The prevalence 
of otoneurologic complaints was: headache (23.3%), vertigo 
(16.6%), and tinnitus (13.3%). The prevalence of associated 
complaints and habits was: caffeine abuse (20.0%), allergies 
(10.0%), and alcohol abuse (10.0%). The prevalence of normal 
auditory thresholds was 90.0%. Acoustic impedance showed 
no changes. The vestibular test showed changes in 60.0% of 
cases. Peripheral vestibular deficiency syndromes were also 
found. Conclusions: Significant vestibular system changes 
were found (60.0%) compared to the auditory system (10.0%). 
Audiometry revealed mostly normal results. The vestibular 
test showed changes in the peripheral vestibular system and 
the peripheral vestibular deficiency syndrome. 
Keywords: diabetes mellitus, vestibular diseases, vestibular 
function test.
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INTRODUCTION
The most important non-transmissible diseases 
(NTD) for public health in Latin America and the Caribbean 
region are cardiovascular diseases, cancer and diabetes 
mellitus (DM). Of these, DM is considered an economic, 
social and personal burden for institutions and families.1 
The current world diabetic population is about 135 million 
people,2 a number that might reach 221 million by 2010.3 
This increase will be significant in Latin America, as 80% 
of life-years lost due to DM-caused incapacity occur in 
developing countries.4
Estimates for 2025 show that there may be about 
11 million diabetics in Brazil, an increase of more than 
100% compared to the current number (five million 
diabetics).3
A multicentric study on the prevalence of DM in 
nine Brazilian capital cities between 1986 and 1988 in the 
urban population aged between 30 and 69 years revealed 
that the prevalence of DM is 7.6%. It is believed that a lon-
ger life span has led to an increased prevalence of DM.5
DM may be defined as a metabolic disorder in whi-
ch a relative or absolute insulin deficiency causes chronic 
hyperglycemia.6
Metabolic alterations in DM alter the carbohydrate, 
lipid and protein metabolism in the human body. The di-
sease interferes with the metabolism of glucose and other 
energy-producing substances.7
The etiological classification of glucose disorders by 
the World Health Organization is based on work done by 
the National Diabetes Data Group (NDDP) in the United 
States of America. The NDDP suggests classifying DM and 
other states of glucose intolerance into three subclasses, as 
follows: type 1, type 2 and secondary diabetes associated 
with another identifiable condition or syndrome.8
DM is considered the main cause of blindness, of 
end-stage renal failure and of non-traumatic amputation 
during the productive age. DM increases the risk of car-
diovascular and cerebral diseases 2 to 7-fold, and is also 
an important cause of neonatal morbidity. Recent data 
have shown that most of the debilitating complications 
of the disease may be avoided or delayed by the pros-
pective treatment of hyperglycemia and of cardiovascular 
risk factors.8
Glucose metabolism significantly influences 
the physiology of the inner ear, which is very active 
metabolically.9-13
The inner ear does not store energy, so minor 
variations in blood glucose affect its function and cause 
balance disorders.9-13 Altered inner ear metabolism may 
lead to potassium transfer from the endolymph to the 
perilymph and an opposite movement of sodium. This 
mechanism may cause vertigo, tinnitus, hypoacusis and 
ear fullness.13
Various studies14-16 have shown that both the pe-
ripheral and central vestibular systems may be altered in 
type 1 DM patients.
The aim of this study was to investigate vestibulo-
cochlear manifestations in patients with type 1 DM.
MATERIAL AND METHODS
Thirty patients (17 males and 13 females) aged 
between 7 and 56 years (mean age - 25.7 years) with a 
diagnosis of type 1 DM were assessed.
The study was a cross-sectional contemporary co-
hort trial in which patients were assessed independently 
of the type and duration of treatment.
The study was approved by the institutional Rese-
arch Ethics Committee (protocol number 009/2005).
Patients signed the free informed consent form 
before undergoing the following procedures:
Clinical history
A questionnaire was applied, emphasizing oto-
neurological signs and symptoms, and the personal and 
family history. Patients with other diseases besides type 1 
DM were excluded.
Otorhinolaryngological evaluation
This assessment was one to exclude conditions that 
might interfere with auditory tests.
Audiological evaluation
Conventional pure tone audiometry was done 
using an Interacoustics AC 40 audiometer and TDH 39P 
earphones (thresholds in dB NA). The speech recognition 
threshold was done followed by the percentage rate of spe-
ech recognition, in an acoustic booth to avoid interference 
from extraneous noise. The degree and type of hearing 
loss were classified according to Davis and Silverman17 
and Silman and Silverman.18
Acoustic immitance testing
This procedure was done to assess the integrity of 
the ossicular and the tympanic systems; it is based on the 
tympanometric curve and investigation of the acoustic 
reflection. The equipment was an Interacoustics AZ-26 
impedance meter and TDH 39P earphones. Jerger’s19 cri-
teria were used to interpret the results.
Vestibular assessment
Patients underwent the following tests that are part 
of the vestibular assessment based on vectoelectronystag-
mography (VENG):
Unrecorded:
Open eye unrecorded positional nystagmus was 
investigated to investigate the presence of nystagmus 
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and/or vertigo associated with bodily changes, based on 
Brandt and Daroff’s20 maneuver. Open eye spontaneous 
and semispontaneous nystagmus in frontal gazing and 
at 30° to the right, to the left, upwards and downwards 
was done.
 
Recorded:
A Berger VN316 three-channel thermosensitive de-
vice was used for measuring VENG. Skin around the orbits 
was cleaned using an alcohol solution; on each patient an 
active electrode was placed on the lateral angle of each eye 
and on the frontal midline, forming an isosceles triangle 
(electrolytic paste was used for fixation). This setup made 
it possible to check horizontal, vertical and oblique eye 
movements. This form of VENG provided us with precise 
measurements of the slow component angular velocity 
(vestibular correction) of nystagmus. A Ferrante rotating 
descending pendular rotating chair, a Neurograff model 
EV VEC visual stimulator and a Neurograff model NGR 05 
air otocalorimeter were used at air temperatures of 42°C, 
20°C and 10°C for caloric tests.
The following ocular and VENG labyrinth tests 
were done according to Mangabeira-Albernaz, Ganança 
and Pontes’s21 criteria:
* calibration of ocular movements: regularity of 
tracings were assessed to enable comparisons between 
studies.
* testing of spontaneous nystagmus (open and clo-
sed eyes) and semispontaneous nystagmus (open eyes): 
the presence, direction, inhibiting effect of ocular fixation 
(IEOF) and the maximum slow component angular velocity 
(SCAV) of nystagmus were assessed.
* pendular tracking test: the presence and type of 
curve were assessed;
* optokinetic nystagmus test: the presence, direc-
tion, maximum SCAV with clockwise and anticlockwise 
movement of the light source were assessed, and the 
preponderant direction of nystagmus was calculated.
* investigation of pre- and post-rotatory nystagmus 
by the pendular swing rotatory test with stimulation of 
the anterior, lateral and posterior semicircular canals: the 
presence, direction, frequency after anticlockwise and 
clockwise rotation and calculation of the preponderant 
direction were noted.
* investigation of pre- and post-caloric nystagmus: 
done with the patient’s head and trunk tilted backwards 
by 60° for adequate stimulation of the lateral semicircular 
canals. Stimulation time for each ear was 80 sec per ear 
at each temperature (42°C, 20°C and 10°C) and responses 
were recorded with eyes closed and then with eyes open to 
observe IEOF. The direction, absolute values of SCAV and 
calculation of the preponderant direction and labyrinthic 
predominance of post-caloric nystagmus.
RESULTS
Patient complaints, the clinical history and habits 
are shown on Tables 1 and 2.
Table 1. Frequency of otoneurological complaints in the clinical 
history of 30 patients with type 1 diabetes mellitus.
Otoneurologic Complaints
 N. Of Patients Frequency (%)
Headache 7 23.3
Rotating Dizziness 5 16.6
Tinnitus 4 13.3
Listening Difficulties 3 10.0
Non-rotating Dizziness 2 6.6
Ear Pain 1 3.3
Sensitivity To Sound 1 3.3
Key: N. - number.
Table 2. Frequency of associated complaints, personal history and 
habits in the clinical history of 30 patients with type 1 diabetes melli-
tus.
Associated Complaints
 N. Of Patients Frequency (%)
Caffeine Abuse 6 20.0
Allergy 3 10.0
Alcohol Abuse 3 10.0
Low Blood Pressure 2 6.6
Smoking 2 6.6
Tingling Of Extremities 2 6.6
Nightmares 1 3.3
Darkened Vision 1 3.3
Sweating 1 3.3
Key: N. - number.
Table 3. Audiological findings in 30 patients with type 1 diabetes 
mellitus.
Findings N. Of Patients Frequency (%)
N.a.t. 27 90.0
Descending Bilateral M.s.h.l. 2 6.7
Flat Bilateral M.s.h.l. 1 3.3
Total 30 100.0
Key: N.A.T. - normal auditory thresholds; descending bilateral M.S.H.L. 
- descending bilateral moderate sensorineural hearing loss; flat bila-
teral M.S.H.L. - flat bilateral moderate sensorineural hearing loss; N. 
- number.
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Audiological tests revealed alterations in three ca-
ses (10 %), as follows: one case of flat bilateral moderate 
sensorineural hearing loss and two cases of descending 
bilateral moderate sensorineural hearing loss, as shown 
on Table 3.
Tests for vertigo and/or positional nystagmus, ca-
libration of ocular movements, spontaneous nystagmus 
(open and closed eyes), semispontaneous nystagmus 
(open eyes), pendular tracking, optokinetic nystagmus and 
per-rotatory nystagmus were within normal limits. Altered 
VENG results were those of the caloric test.
Vestibular function testing revealed changes in the 
peripheral vestibular system in 18 cases (60 %). The vesti-
bular exam was within normal limits in 12 cases (40 %).
Absolute and relative values of caloric stimulation 
testing are shown on Table 4.
Results of vestibular testing were as follows: 12 
cases (40 %) were within normal limits, 12 cases (40 %) 
presented the peripheral vestibular syndrome, and 6 cases 
(20 %) presented irritative peripheral vestibular syndrome, 
as shown on Table 5.
Vestibular alterations were found in 18 cases (60 %) 
and auditory alterations were found in 3 cases (10 %). Of 
these, two cases had both of these changes.
DISCUSSION
Patients with altered glucose metabolism may 
present auditory and vestibular signs and symptoms. 
The most prevalent otoneurological complaints in our 
study were as follows: headache - seven cases (23.3%), 
rotatory dizziness - five cases (16.6%) and tinnitus - four 
cases (13.3%). Various published papers22,23 have reported 
these symptoms in metabolic disease. The inner ear is 
particularly sensitive to altered blood glucose and insulin 
levels; the most common symptoms are vertigo, hearing 
loss, tinnitus and ear fullness, among others. Vascular 
striae depend on a constant concentration of blood glu-
cose; variations of blood glucose may cause auditory and 
balance disorders.13
The most prevalent associated complaints and 
other referred habits were the following: caffeine abuse 
- six cases (20 %), allergy - three cases (10 %) and alcohol 
abuse - three cases (10 %). Ganança, Dias and Ganança24 
noted that caffeine acts as a diuretic and its stimulating 
effect may worsen symptoms such as vertigo and tinnitus. 
Alcohol abuse may directly affect the inner ear by changing 
the concentration of its liquids; this effect may cause or 
augment cochleovestibular symptoms.
Vestibular alterations were seen in 18 cases (60 %) 
and hearing loss was observed in three cases (10 %). Of 
these, two cases had both disturbances. Metabolic disor-
ders may affect the homeostasis of the vestibular organ 
more rapidly than the auditory system.16 Gawron et al.16 no-
ted that vestibular testing appeared to be more sensitive in 
detecting central nervous system disorders in DM patients 
compared to audiological testing. In this same paper, the 
authors found that auditory tests and acoustic immitance 
testing were within normal limits in these patients, even 
though most of them revealed central alterations when 
assessed by vestibular testing.
Maia and Campos25 stated that there is no consensus 
between audiological and histopathological findings in 
type 1 DM. We found three cases (10 %) of sensorineural 
hearing loss; one of theses cases (3.3%) had flat bilateral 
moderate sensorineural hearing loss, and two cases (6.6%) 
had descending bilateral moderate sensorineural hearing 
loss. Clinical trials have revealed a relation between hea-
ring loss and DM. Camisasca26 found sensorineural hearing 
loss in 46% of cases, although the degree and configuration 
were not mentioned in this study. Jorgensen and Buch27 
reported bilateral sensorineural hearing loss in 41% of 
cases. Khasanov, Vasilyeva and Mazovetsky14 reported 
hearing loss and vestibular involvement in 18 cases (43 
%). Biurrun et al.15 found 11 cases (23.9%) of mild senso-
rineural hearing loss mostly at high frequencies, with no 
associated auditory complaints. Almeida28 found five cases 
(20 %) with sensorineural hearing loss (unreported degree) 
in a study of patients with glucose metabolic disorder.
Table 4. Caloric stimulation testing - post-caloric nystagmus (absolu-
te and relative values) in 30 patients with type 1 diabetes mellitus.
Findings N. Of Patients Frequency (%)
Normoreflexia 12 40.0
Bilateral Labyrinthic Hyporeflexia 10 33.3
Unilateral Labyrinthic Hypore-
flexia 
2  6.7
Bilateral Labyrinthic Hypereflexia 5 16.7
Unilateral Labyrinthic Hypere-
flexia
1  3.3
Total 30 100.0
Key: N. - number.
Table 5. Results of vestibular testing in 30 patients with type 1 diabe-
tes mellitus.
Findings N. Of Patients Frequency (%)
N.v.t. 12 40.0
D.p.v.s. 12 40.0
I.p.v.s. 6 20.0
Total 30 100.0
Key: N.V.T. - normal vestibular test; D.P.V.S - deficient peripheral ves-
tibular syndrome; I.P.V.S. - irritating peripheral vestibular syndrome; 
N. - number.
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Inner ear blood vessel involvement and alterations 
of the vascular striae in DM patients have been establi-
shed by various authors to suggest a connection between 
hearing loss and DM. These changes strongly suggest that 
DM causes hearing loss.27,29-32
We found 18 cases (60 %) with altered vestibular 
tests. These findings are similar to published results15,6,33,34 
that have also shown altered vestibular tests.
Biurrun et al.15 have suggested that recently diag-
nosed DM patients show no vestibular test abnormalities. 
They raised the hypothesis that the effect of DM on ves-
tibular function might be caused by complications such 
as diabetic neuropathy and angiopathy, which are absent 
in initial phases of the disease. Various authors27,29-31 have 
previously suggested that microangiopathy might be res-
ponsible for DM-associated altered inner ear function.
Vestibular testing is essential for investigating bodily 
balance; the importance of caloric stimulation testing is its 
ability to assess each labyrinth separately.
Abnormal VENG findings were uncovered in caloric 
stimulation testing. Other tests, such as the presence of 
vertigo and/or positional nystagmus, calibration of ocular 
movements, open and closed eye spontaneous nystagmus, 
open eye semispontaneous nystagmus, pendular tracking, 
optokinetic nystagmus and per-rotating nystagmus re-
vealed no changes. Scherer and Lobo34 found altered 
electronystagmographies in 87.5% of subjects; in 12.5% of 
cases the diagnosis was based on positional nystagmus. 
Biurrun et al.15 found seven cases (15.2%) with sponta-
neous nystagmus and 12 cases (26.1%) with positional 
nystagmus. Almeida28 found over 50% of altered caloric 
stimulation tests; pendular tracking was the second test 
with most alterations.
We found 12 cases (40 %) of normoreflexia, 12 
cases (40 %) of hyporeflexia and 6 cases (20 %) of hype-
reflexia. These findings are similar to those of Biurrun et 
al.,15 Camisasca,26 and Aantaa and Lehtonen,33 who noted 
that hyporeflexia is more prevalent that hypereflexia, di-
fferent from studies by Scherer and Lobo,34 and Cojazzi.35 
Mangabeira-Albernaz12 contend that both hypereflexia and 
hyporeflexia may occur, which would explain the paucity 
of crises of vertigo.
We found 18 cases (60 %) of peripheral vestibular 
involvement, of which 13 cases (43.3%) had no dizziness, 
similar to findings by Ramos et al.10 who stated that DM 
patients using insulin have less dizziness, which would 
explain the low rate of dizziness in our sample. Jerger 
and Jerger36 contend that 20% of DM patients may present 
dizziness. Some patients, however, have no complaints. 
Scherer and Lobo34 found altered vestibular function in 
75% of subjects, with 62.5% presenting no otoneurological 
complaints. According to Munhoz et al.,22 absent vestibular 
symptoms associated in the presence of altered vestibular 
tests may be a sequelae of a previous disorder that is not 
always evident in the clinical history; active vestibular 
disease may also be a possible explanation.
Peripheral vestibular involvement was found in 
100% of the 18 cases that had altered vestibular function. 
This finding diverge from those in studies by Khasanov, 
Vasilyeva and Mazovetsky,14 and Gawron, Pospiech, 
Orendorz-Fraczkowska and Noczynska16 who observed 
that metabolic disorders found in type 1 DM caused 
changes in different segments of the vestibular organ, but 
mostly in the central portion.
CONCLUSION
- Otoneurological complaints included headache 
(23.3%), rotating dizziness (16.6%) and tinnitus (13.3%). 
Associated complaints and habits included caffeine abuse 
(20 %), alcohol abuse (10 %) and allergy (10 %).
- There were more changes in the vestibular system 
(60 %) compared to the auditory system (10 %). Auditory 
testing was mostly within normal limits. Vestibular testing 
revealed alterations in the peripheral vestibular system and 
the deficient peripheral vestibular syndrome.
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